Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Arrow – Combipramol
Active Ingredients: Ipratropium bromide monohydrate 0.2088%w/v equivalent to ipratropium 0.2%w/v
Salbutamol sulphate 0.12%w/v equivalent to 0.1% salbutamol base
Dosage Form: Solution for inhalation
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Laboratoire Unither, Zone Industrielle Longpre, Amiens Cedex 2, France
Product: m-Cefotaxime
Active Ingredient: Cefotaxime sodium 1.076g equivalent to cefotaxime 1g
Dosage Form: Powder for injection
Diluent
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Reig Jofre SA, Sant Adria de Besos, Barcelona, Spain
Dated this 16th day of June 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).